Cinacalcet: all 58 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Novel Combination Therapy for Osteoporosis in MenCompletedNCT03994172Phase 4Results posted
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.CompletedNCT03027557Phase 3Results posted
- Renal Osteodystrophy: An Individual Management ApproachCompletedNCT02440581Not applicableResults posted
- Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedNCT02341417Phase 3Results posted
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTerminatedNCT02138838Phase 3Results posted
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedNCT01439867Phase 2Results posted
- Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedNCT01290029Phase 1Results posted
- Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedNCT01277510Phase 3Results posted
- Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing HemodialysisCompletedNCT01181531Phase 4Results posted
- Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate CancerCompletedNCT01054079Phase 2Results posted
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin DCompletedNCT00977080Phase 4Results posted
- Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo ParathyroidectomyCompletedNCT00975221Phase 3Results posted
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 3Results posted
- 20070360 Incident DialysisCompletedNCT00803712Phase 4Results posted
- A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)CompletedNCT00431496Phase 4Results posted
- Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedNCT00415584Phase 1/2Results posted
- E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCompletedNCT00345839Phase 3Results posted
- Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal DiseaseCompletedNCT00261950Phase 2Results posted
- A Research Study for Patients With End-Stage Renal Disease (ESRD)CompletedNCT00110890Phase 4Results posted
- Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCompletedNCT00042432Phase 2Results posted
- Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular HemodialysisCompletedNCT05926570Phase 4
- Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet TreatmentCompletedNCT04637360Not applicable
- Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)CompletedNCT03776058Phase 2
- Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary HyperparathyroidismCompletedNCT03774771Phase 2
- Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedNCT03123406Phase 4
- Efficacy of Cinacalcet in the Control of Primary HyperparathyroidismCompletedNCT02417389Phase 4
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?CompletedNCT02227264Not applicable
- The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of ParathyroidCompletedNCT02056730Phase 4
- Influence of Cincalcet on Cognitive Functions in Healthy Human SubjectsCompletedNCT01599962Phase 2
- Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone SystemCompletedNCT01519037Not applicable
- Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)Status unknownNCT01479088Phase 2/3
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 3
- Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis PatientsCompletedNCT01447368Phase 4
- Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis PatientsCompletedNCT01250405Phase 4
- Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal TransplantationCompletedNCT01178450Phase 4
- Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary HyperparathyroidismCompletedNCT01143987Phase 4
- Evaluation of a Cincalcet Suppression TestCompletedNCT01103206Phase 4
- Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH LevelCompletedNCT01101113Phase 4
- Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney TransplantTerminatedNCT01011114Not applicable
- Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493CompletedNCT00952094Phase 1
- A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary HyperparathyroidismCompletedNCT00936988Phase 2
- A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)CompletedNCT00936650Phase 2
- Calcimimetics in Hypophosphatemic RicketsWithdrawnNCT00844740Not applicable
- Safety and Efficacy Study of AMG 073 in Hemodialysis SubjectsCompletedNCT00527267Phase 3
- 12-month Study of AMG 073 in Renal OsteodystrophyCompletedNCT00527085Phase 2
- Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisTerminatedNCT00446329Phase 4
- The Effect of Cinacalcet on Gastric Acid Output in Healthy SubjectsCompletedNCT00336739Not applicable
- Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsCompletedNCT00195936Phase 1
- ACHIEVE: Optimizing the Treatment of Secondary HyperparathyroidismCompletedNCT00135304Phase 4
- START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary HyperparathyroidismCompletedNCT00132431Phase 4
- SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary HyperparathyroidismCompletedNCT00117052Phase 3
- Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) LevelsCompletedNCT00113958Phase 2
- Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)CompletedNCT00113945Phase 2
- Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)CompletedNCT00110929Phase 2
- Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving DialysisCompletedNCT00094484Phase 3
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on DialysisCompletedNCT00042653Phase 3
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis PatientsCompletedNCT00037635Phase 3
- A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid CancerCompletedNCT00037518Phase 4